Haci Celik, MD
Ophthalmology · Miami, FLNPI 1275055741
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,368 of the $2,257 with a category attached, or 60.6%. Bausch & Lomb Americas Inc. accounts for 84.1% of it on its own, with 5 other manufacturers making up the rest. 2025 is the largest year on record at $1,913, more than ten times the $149 reported in 2022.
Across 17 payments — averaging $132.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bausch & Lomb Americas Inc.$2K
- Rxsight Inc$91
- Glaukos Corporation$89
- Johnson & Johnson Surgical Vision, Inc.$76
- Carl Zeiss Meditec, Inc.$60
- Alcon$44
What the payments were for
- Travel & lodging$1,36861%
- Food & beverage$88939%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bausch & Lomb Americas Inc. | 9 | $1,897 |
| Rxsight Inc | 1 | $91 |
| Glaukos Corporation | 1 | $89 |
| Johnson & Johnson Surgical Vision, Inc. | 2 | $76 |
| Carl Zeiss Meditec, Inc. | 1 | $60 |
| Alcon | 3 | $44 |
How this compares
$2,257 in reported general payments places this provider in the 55th percentile of 1,405 ophthalmology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 24 | $17,606 |
| Prednisolone Acetate | 390 | $10,620 |
| MoxifloxacinMoxifloxacin Hcl | 299 | $7,462 |
| Ketorolac Tromethamine | 295 | $4,953 |
| ValacyclovirValacyclovir Hcl | 17 | $1,290 |
| Latanoprost | 18 | $331 |
| Timolol Maleate | 33 | $249 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Miami
- William TrattlerMiami$579K
- Jennifer LohMiami$545K
- Jayanth SridharMiami$525K
- Kendall DonaldsonMiami$349K
- Jaclyn KovachMiami$333K
- Andrew SchimelMiami$320K
- Carlos BuznegoMiami$287K
- Felipe MedeirosMiami$266K
- Michael YimMiami$161K
- Arnulfo MansurMiami$134K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.